Treatment

ASSET is close to its conclusion and a concluding conference will be held in Rome, on October 30-31, to present all the main outcomes of the project. This event will take place at the hotel NH Roma Leonardo Da Vinci and will be targeted to a selected audience of EU stakeholders and policy makers. Its aim is to enhance advocacy and intersectoral approach in a multisetting scenario applied to fostering preparedness and response toward Public Health Emergency of International Concern (PHEIC), like epidemics and even pandemics.

ASSET is close to its conclusion and a concluding conference will be held in Rome, on October 30-31, to present all the main outcomes of the project. This event will take place at the hotel NH Roma Leonardo Da Vinci and will be targeted to a selected audience of EU stakeholders and policy makers. It is conceived as a mobilization and mutual learning event at local, national and international levels on Science in Society related issues in epidemics and pandemics.

Drug Approval Regulation in Canada and USA

Since the thalidomide tragedy in the late1950s, there has been a reluctance to include women of childbearing age in clinical trials. However, this fear cannot be used as an excuse to not include females in clinical trials, and, with proper care and regulation, increased female participation has been reached. The United States adopted regulation early on to increase the participation of women, while a new regulation in Europe is going to improve this as well. Here follows an overview of the issue in Canada and in the USA. The third part of this series will deal with new regulation in Europe.